The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders
- PMID: 34712575
- PMCID: PMC8528787
- DOI: 10.1016/j.ymgmr.2021.100812
The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders
Abstract
Considering that some Inherited Metabolic Disorders (IMDs) can be diagnosed in patients with no distinctive clinical features of IMDs, we aimed to evaluate the power of exome sequencing (ES) to diagnose IMDs within a cohort of 547 patients with unspecific developmental disorders (DD). IMDs were diagnosed in 12% of individuals with causative diagnosis (177/547). There are clear benefits of using ES in DD to diagnose IMD, particularly in cases where biochemical studies are unavailable.
Synopsis: Exome sequencing and diagnostic rate of Inherited Metabolic Disorders in individuals with developmental disorders.
Keywords: Developmental delay; Exome sequencing; Genotype first; Inherited metabolic disorders; Intellectual disability.
© 2021 Published by Elsevier Inc.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Ezgu F. Inborn errors of metabolism. Adv. Clin. Chem. 2016;73:195–250. - PubMed
-
- Tarailo-Graovac M., Wasserman W.W., Van Karnebeek C.D.M. Impact of next-generation sequencing on diagnosis and management of neurometabolic disorders: current advances and future perspectives. Expert. Rev. Mol. Diagn. 2017;17:307–309. - PubMed
-
- Ghosh A., Schlecht H., Heptinstall L.E. Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing. Arch. Dis. Child. 2017;102:1019–1029. - PubMed
-
- Nambot S., Thevenon J., Kuentz P. Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis. Genet Med. 2018;20:645–654. - PubMed
Publication types
LinkOut - more resources
Full Text Sources